31
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virological suppression

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Absence of detectable viraemia after treatment cessation in some vertically HIV-infected (VHIV) children suggests that early initiation of HAART could lead to functional cure.

          Objectives: We described the factors associated with HIV antibody levels and the viral reservoir size in HAART-treated VHIV children.

          Methods: Study included 97 VHIV children with virological suppression, in Bamako, Mali. The anti-gp41 antibody activities and HIV serostatus were assessed. The viral reservoir size was measured by quantifying total cell-associated HIV DNA.

          Results: Among the children studied, the median total HIV DNA level was 445 copies/10 6 cells (IQR = 187–914) and the median anti-gp41 antibody activity was 0.29 OD (IQR = 0.18–0.75). Low activity of anti-gp41 antibodies was associated with a younger age of HAART initiation ( P = 0.01). Overall, eight HIV-1 seroreversions were identified.

          Conclusions: Study identified potential candidates with low viral reservoir and low antibody levels or activities for future trials aiming to reduce HIV-1 reservoir to limit HAART duration.

          Related collections

          Author and article information

          Journal
          J Antimicrob Chemother
          J. Antimicrob. Chemother
          jac
          Journal of Antimicrobial Chemotherapy
          Oxford University Press
          0305-7453
          1460-2091
          April 2017
          30 December 2016
          : 72
          : 4
          : 1147-1151
          Affiliations
          [1 ]Sorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d’épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris F75013, France
          [2 ]Department of Virology, Hôpital Pitié-Salpêtrière, AP-HP, Paris F75013, France
          [3 ]Department of Pediatric, University Hospital Gabriel Toure, Bamako, Mali
          [4 ]Unité d'Epidémiologie Moléculaire de la Résistance du VIH aux ARV, SEREFO, FMOS, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali
          [5 ]Division of Infectious Diseases, Feinberg School of Medicine, Northwestern University, 645 N Michigan Avenue, Suite 900, Chicago, IL 60611, USA
          [6 ]CHRU de Tours, French reference centre of HIV, Virologic laboratory, Tours, France
          [7 ]Africa Health Research Institute, Durban, South Africa
          [8 ]Clinical and Microbiology Laboratory, University Hospital Gabriel Toure, Bamako, Mali
          Author notes
          [* ]Corresponding author. Tel: +33-1-42-17-74-28; Fax: +33-1-42-17-74-11; E-mail: josephine.brice@ 123456gmail.com
          Article
          PMC6251631 PMC6251631 6251631 dkw537
          10.1093/jac/dkw537
          6251631
          28039275
          fe1fe8d5-e135-44d2-8749-4e605d1f0e6a
          © The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
          History
          : 05 July 2016
          : 15 September 2016
          : 11 November 2016
          : 15 November 2016
          Page count
          Pages: 5
          Funding
          Funded by: Agence Nationale de Recherche sur le Sida et les Hépatites virales
          Categories
          Original Research

          Comments

          Comment on this article